Entera Bio Ltd. (ENTX)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
- Fiscal year ends Dec 31
In fiscal 2025, Entera Bio Ltd. reported revenue of $42.0K, down 76.8% from the prior year. The company ran a net loss, with a net margin of -27235.7% and a gross margin of 0.0%. It held $15.99M in total assets against $2.89M in total liabilities.
Key ratios (FY2025)
0.0%
Gross margin
-27450.0%
Operating margin
-27235.7%
Net margin
-87.3%
Return on equity
-76.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | — |
| Cost of Revenue | $42.0K | $172.0K | $0 | $101.0K | $373.0K | $300.0K | — |
| Gross Profit | $0 | $9.0K | $0 | $33.0K | $198.0K | $65.0K | — |
| Operating Income | -$11.53M | -$9.59M | -$8.89M | -$13.02M | -$12.22M | -$11.17M | — |
| Net Income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | — |
| EPS (Diluted) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | — | — |
| Total Assets | $15.99M | $9.39M | $11.77M | $13.13M | $25.99M | $9.72M | — |
| Total Liabilities | $2.89M | $1.31M | $1.38M | $1.37M | $3.42M | $2.21M | — |
| Shareholders' Equity | $13.10M | $8.08M | $10.39M | $11.75M | $22.57M | $7.51M | $13.77M |
| Cash & Equivalents | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | $8.59M | — |
| Operating Cash Flow | -$7.37M | -$6.82M | -$7.31M | -$12.50M | -$9.06M | -$10.56M | — |
| Capital Expenditures | $107.0K | $3.0K | $17.0K | $47.0K | $17.0K | $53.0K | — |
| Shares Outstanding | 46.18M | 38.84M | 35.48M | 28.81M | 28.80M | 21.06M | — |